KBC Group
NARI

KBC Group’s Inari Medical, Inc. Common Stock NARI Stock Holding History

KBC Group’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,333
Closed -$119K – 1902
2024
Q4 		$119K Buy
2,333
+559
+32% +$27.5K ﹤0.01% 1437
2024
Q3 		$73K Buy
1,774
+498
+39% +$23.9K ﹤0.01% 1499
2024
Q2 		$61K Buy
1,276
+157
+14% +$6.96K ﹤0.01% 1505
2024
Q1 		$54K Hold
1,119
– – ﹤0.01% 1517
2023
Q4 		$73K Hold
1,119
– – ﹤0.01% 1271
2023
Q3 		$73K Buy
+1,119
New +$70.4K ﹤0.01% 1161

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $281M AUM 17.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

KBC Group's NARI Position: Q1 2025 in Review

KBC Group sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 2,333 shares — an estimated $119K sold.

KBC Group first reported a position in NARI in Q3 2023 and held it in 6 quarters. The position peaked at $119K in Q4 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • KBC Group reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • KBC Group sold 2,333 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $119K.
  • KBC Group first reported a position in Inari Medical, Inc. Common Stock in Q3 2023 and held it in 6 quarters.
  • KBC Group's Inari Medical, Inc. Common Stock position peaked at $119K in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on KBC Group's 13F filing for Q1 2025, filed 25 Apr 2025.